HomeOncologyBreast CancerDrug approval for breast cancer

Drug approval for breast cancer

The U.S. Food and Drug Administration has approved Tykerb (lapatinib) in combination with Femara (letrozole) to treat hormone positive and HER2-positive advanced breast cancer in postmenopausal women for whom hormonal therapy is indicated.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content